Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models

Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models

Administration of mRNA against SARS-CoV-2 has demonstrated sufficient efficacy, tolerability and clinical potential to disrupt the vaccination field. A multiple-arm, cohort randomized, mixed blind, placebo-controlled study was designed to investigate the in vivo expression of mRNA antibodies to immu...

Full description

Bibliographic Details
Main Authors: Andreas Ouranidis, Theodora Choli-Papadopoulou, Eleni T. Papachristou, Rigini Papi, Nikolaos Kostomitsopoulos
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Vaccines
Subjects:
mRNA encoded antibodies
SARS–CoV-2
COVID-19
Trastuzumab
mRNA-vaccines
pharmacokinetics
Online Access:https://www.mdpi.com/2076-393X/9/8/890

Internet

https://www.mdpi.com/2076-393X/9/8/890

Similar Items